Shares of Lexicon Pharmaceuticals (LXRX) experienced a significant downturn in Friday's trading session, plummeting 7.69% following the company's announcement of a new stock offering. The sharp decline comes as investors react to the potential dilution of their shareholdings.

According to multiple SEC filings, Lexicon Pharmaceuticals has filed for an offering of up to $75 million of common stock. This move, while potentially providing the company with additional capital for operations or expansion, has sparked concerns among existing shareholders about the dilution of their ownership stakes.

The timing of this announcement, made after market hours on Thursday, led to the stock's dramatic fall during Friday's trading. Stock offerings of this nature often lead to share price declines as the market adjusts to the prospect of increased share supply. Investors will be closely watching how Lexicon plans to utilize the funds raised from this offering and whether it will translate into long-term value for shareholders.